Active ingredientTesofensineCat. No. P-T069-001CAS 195875-84-4Family · Pharmaceutical analytical standards
Tesofensine
A serotonin, noradrenaline and dopamine reuptake inhibitor of the phenyltropane family, developed in Denmark and studied since the early 2000s, later mainly as a possible treatment for obesity. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was born as a drug for Parkinson's and Alzheimer's, but in trials one 'side effect' kept coming back, weight loss, so researchers decided to develop it against obesity.
Go to the active ingredient →Active ingredientTesofensineCat. No. P-T069-001CAS 195875-84-4
Active ingredientTesofensine CitrateCat. No. P-T069-002CAS 195875-86-6
Isotopically labelledTesofensine-13C-d3Cat. No. P-T069-003
Isotopically labelledTesofensine-d5Cat. No. P-T069-004
ImpurityTesofensine (1R,2S,3R,5S)-IsomerCat. No. P-T069-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.